2023-09-28

Triastek Completes USD 20.4 Million Pre-C Funding Round to Accelerate Commercialization of 3D Printing Pharmaceutical Technology and Products

2023-08-16

CRS 2023 Poster Presentation | MED Process Provides New Ideas for Insoluble Drugs' Development

2023-07-20

Triastek shares positive results from T21 study showcasing the 3D printing technology’s ability to effectively target and release medication in the colon

2023-06-08

Triastek Honored with 2023 Healthcare Application Award at the TCT Awards Ceremony

2023-03-31

Triastek has been named to J.P. Morgan Private Bank's 'Top 100 Women-Powered, High-Growth Businesses in Asia Pacific'

2023-03-17

Triastek Announces Collaboration with Boehringer Ingelheim to Advance and Accelerate Research and Development of Innovative Pharmaceutical Products with MED® 3D Printing Technology